Cardiovascular disease risk factors

Agamah, E.S., Srinivasan, S.R., Webber, L.S. and Berenson, G.S. (1991). Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biorac-ical community The Bogalusa Heart Study. J. Lab. Clin. Med. 113, 241-249. 

Symptoms The primary hypertension patient may be asymptomatic or may have major cardiovascular disease risk factors. 

Perez-Jimenez J, Serrano J, Tabernero M, Arranz S, Diaz-Rubio ME, Garcia-Diz L, Goni I and Saura-Calixto F. 2008. Effects of grape antioxidant dietary fiber on cardiovascular disease risk factors. Nutrition 24 646-653. 

HV169 Keogh G. F., G. J. Cooper, T. B. Mulvey, et al. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 2003 78(4) 711-718. 

Sagara M, Kanda T, Njelekera M et al. Effects of dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle-aged men in Scotland. J. Am. Coll Nutr. 23, 85-91, 2004. 

Atkinson C, Oosthuizen W, Scollen et al. Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. J. Nutr. 134, 1759-1764, 2004. 

Chardigny, J. M., Destaillats, F., Malpuech-Brugere, C., Moulin, J., Bauman, D. E., Lock, A. L., Barbano, D. M., Mensink, R. P., Bezelgues, J. B., Chaumont, P., Combe, N., Cristiani, I., et al. (2008). Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am. ]. Clin. Nutr. 87, 558-566. 

Thomas VL, Gropper SS. 1996. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol Tace Elem Res 55 297-305. 

Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, Shahar E, Nieto J, Mosley T, Heiss G (1997) The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors the ARIC Study. Neuroepidemiology 16 149-162 Lie C, Hirsch JG, Rossmanith C, Hennerici MG, Gass A (2004) Clinicotopographical correlation of corticospinal tract stroke a color-coded diffusion tensor imaging study. Stroke. 35 86-92... 

Ludwig, D. S. et al., Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults, J. Am. Med. Assoc., 282, 1539, 1999. 

Non-Traditional Cardiovascular Disease Risk Factors and Arterial Inflammatory Response in End-Stage Renal Disease... 

T. Ozben /Non-Traditiom Cardiovascular Disease Risk Factors... 

C. Kitiyakara, J. Gonin, Z. Massy and C. S. Wilcox, Non-Traditional Cardiovascular Disease Risk Factors in End-Stage Renal Disease Oxidative Stress and Hyperhomocysteinemia, Current Opinion in Nephrology and Hypertension 9 (2000) 477-487. 

Chukwuma, C. Sr. and Tuomilehto, J. The thrifty hypotheses clinical and epidemiological significance for non-insulin-dependent diabetes mellitus and cardiovascular disease risk factors. Journal of Cardiovascular Risk 5 11-23 1998. 

Q-3 fatty acids lower blood pressure, improve lipids and reduce other cardiovascular disease risk factors [83]. Polyunsaturated fatty acids (PUFA) of the co-3 or eo-6 series have the potential to regulate serum triglycerides and cholesterol levels that are considered important risk factors in cardiovascular pathologies. 

Kris-Etherton, P. M., and J. Dietschy. 1997. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors human and animal studies. American Journal of Clinical Nutrition 65 (Suppl. 5) 1590S-1596S. 

Lichtenstein, A.H. N.R. Matthan S.M. Jalbert N.A. Rcsteghini E.J. Schaefer L.M. Ausman. Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 2006, 84, 497-504. 

Matthan, N.R. S.M. Jalbert L.M. Ausman J.T. Kuvin R.H. BCaras A.H. Lichtenstein. Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am. J. Clin. Nutr. 2007, 85, 960-966. 

Blood pressure and other cardiovascular disease risk factors in black adults with sickle cell trait or glucose-6-phosphate dehydrogenase deficiency. 

---